Home » Clinical Trials » Solid tumors » NCT05287165
NCT05287165

Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms

Study Summary

This is a open-label, single center to determine the efficacy and safety of IM96 CAR-T cells in Patients With Advanced Digestive System Neoplasms

Want to learn more about this trial?

Request More Info

Interventions

IM96 CAR-T cellsDRUG
treatment with anti-GUCY2C chimeric antigen receptor T-cell infusion

Study Locations

FacilityCityStateCountry
Beijing Cancer HospitalBeijingBeijing MunicipalityChina

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026